First, the qualification of new products and validation of new processes take a long time and are highly costly in the pharma industry, and certainly more than in the food industry. Therefore the traditional pharma company changes something in its operations or process only if is not working any more or if there is a specific project with a clear reason to change (e.g. to reduce cost or improve the frequency of monitoring). This is good until some companies realise that the cost of waiting sometimes is higher than the cost of innovating.